# Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study

> **NCT03078712** · NA · COMPLETED · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 424 (actual)

## Conditions studied

- Septic Shock
- Hyperlactatemia
- Peripheral Perfusion

## Interventions

- **OTHER:** Peripheral Perfusion guided resuscitation
- **OTHER:** Lactate guided resuscitation

## Key facts

- **NCT ID:** NCT03078712
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-03-15
- **Final completion:** 2018-06-30
- **Target enrollment:** 424 (ACTUAL)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03078712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03078712, "Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03078712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*